AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $979,000 | -41.6% | 433,400 | -25.5% | 0.08% | -37.5% |
| Q3 2021 | $1,675,000 | -24.4% | 581,700 | -0.5% | 0.12% | -17.8% |
| Q2 2021 | $2,216,000 | +8.2% | 584,600 | -3.4% | 0.15% | -0.7% |
| Q1 2021 | $2,048,000 | +447.6% | 605,100 | +794.7% | 0.15% | +600.0% |
| Q4 2018 | $374,000 | -25.5% | 67,634 | +18.9% | 0.02% | 0.0% |
| Q3 2018 | $502,000 | – | 56,886 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |